Company intelligence / Profile preview
LifeSplice Pharma
Malvern, Pennsylvania, United Stateslifesplicepharma.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Phase 2
01
Overview
LifeSplice Pharma has demonstrated preclinical proof-of-concept for its SMO-based therapies. Lead candidates have shown efficacy in animal models of Dravet Syndrome and ALS, including reduced mortality and delayed disease progression.
- Therapeutic areas
- Neurology
- Modalities
- Splice Modulating Oligomers (SMOs)RNA-based therapeutics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
NIH SBIR Fast Track CREATE grant recipient; no major pharma partnerships disclosed yet
Beyond the preview
Go deeper on LifeSplice Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LifeSplice Pharma.